Lansoprazole Delayed-Release Orally Disintegrating recall: Subpotent
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel…
Why was Lansoprazole Delayed-Release Orally Disintegrating recalled?
Subpotent Drug.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 25Q002, Exp. 11/2019
- Product
- Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel…
- Recalling firm
- Teva Pharmaceuticals USA
- Quantity
- 7,081 bottles
- Distribution
- Nationwide in the United States.
- Recall date
- March 27, 2019
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)